Inc. reported its financial results for the fourth quarter of 2024, revealing a slight miss in earnings per share (EPS) compared to analyst expectations. The company's stock experienced a significant ...
AbbVie Inc. (NYSE:ABBV) discovers, develops, manufactures and sells pharmaceuticals worldwide. It is set to report the Q4 ...